ZA200109993B - Early detection of flaviviruses using the NS1 glycorprotein. - Google Patents

Early detection of flaviviruses using the NS1 glycorprotein.

Info

Publication number
ZA200109993B
ZA200109993B ZA200109993A ZA200109993A ZA200109993B ZA 200109993 B ZA200109993 B ZA 200109993B ZA 200109993 A ZA200109993 A ZA 200109993A ZA 200109993 A ZA200109993 A ZA 200109993A ZA 200109993 B ZA200109993 B ZA 200109993B
Authority
ZA
South Africa
Prior art keywords
glycorprotein
flaviviruses
early detection
early
detection
Prior art date
Application number
ZA200109993A
Inventor
Marie Flamand
Francoise Megret
Sophie Alcon
Antoine Talarmin
Phillippe Despres
Vincent Deubel
Original Assignee
Pasteur Institut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut filed Critical Pasteur Institut
Publication of ZA200109993B publication Critical patent/ZA200109993B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/18—Togaviridae; Flaviviridae
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
ZA200109993A 1999-06-09 2001-12-05 Early detection of flaviviruses using the NS1 glycorprotein. ZA200109993B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9907290A FR2794864A1 (en) 1999-06-09 1999-06-09 Early detection of flavivirus infection, especially dengue fever, comprises detecting non-structural glycoprotein (NS1) in a sandwich assay using antibodies specific for the hexameric protein form

Publications (1)

Publication Number Publication Date
ZA200109993B true ZA200109993B (en) 2002-10-30

Family

ID=9546578

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200109993A ZA200109993B (en) 1999-06-09 2001-12-05 Early detection of flaviviruses using the NS1 glycorprotein.

Country Status (2)

Country Link
FR (1) FR2794864A1 (en)
ZA (1) ZA200109993B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7473424B2 (en) * 2003-01-31 2009-01-06 The Scripps Research Institute Anti-dengue virus antibodies and compositions
SG139546A1 (en) * 2004-07-22 2008-02-29 Nat Environment Agency Diagnostic test
AR070322A1 (en) * 2008-01-30 2010-03-31 Ct Ingenieria Genetica Biotech PROCEDURE FOR THE QUANTIFICATION OF ANTIGEN NS1 OF DENGUE IN IMMUNOCROMATOGRAPHIC STRIP
FR2974907B1 (en) * 2011-05-06 2013-06-14 Biomerieux Sa METHOD FOR DETECTION AND EARLY SEROTYPING OF DENGUE VIRUS
CN116143914B (en) * 2022-12-30 2023-08-22 珠海重链生物科技有限公司 Antibody for dengue virus NS1 protein and related application thereof

Also Published As

Publication number Publication date
FR2794864A1 (en) 2000-12-15

Similar Documents

Publication Publication Date Title
ZA200203581B (en) Bicyclic imidazo-3-yl-amine derivatives.
ZA200000894B (en) 4-Phenyl-pyridine derivatives.
ZA200201055B (en) Amino-triazolopyridine derivatives.
HK1047743A1 (en) New use and novel n-azabicyclo-amide derivatives.
HK1046678A1 (en) Adamantane derivatives.
ZA200200477B (en) 2-pyrazolin-5-ones.
HK1054384A1 (en) 4-Pyrimidinyl-n-acyl-l-phenylalanines.
ZA200109595B (en) 13-methyl-erythromycin derivatives.
ZA200202537B (en) Pour-on-formulations.
HK1046411A1 (en) 5-Phenyl-pyrimidine derivatives.
HK1053470A1 (en) 4-Pyridinyln-acyl-l-phenylalanines.
ZA200207489B (en) Apomorphine derivatives and methods for their use.
HK1027606A1 (en) Shower combination.
ZA200109206B (en) Preparation of substituted piperidin-4-ones.
HK1052925A1 (en) Substituted 1-aminobutan-3-ol derivatives.
ZA200206151B (en) Substituted amionomethyl-phenyl-cyclohexane derivatives.
ZA200205482B (en) Aminosulfonylbiphenyl derivatives.
ZA200109993B (en) Early detection of flaviviruses using the NS1 glycorprotein.
ZA200206150B (en) Aminomethyl-phenyl-cyclohexanone derivatives.
HK1028267A1 (en) The toilet bowl.
MXPA01011285A (en) Thio-oxindole derivatives.
GB0029720D0 (en) I.S machine7544232001
ZA200109120B (en) Use of Arylalkanoylpyridazines.
ZA200300417B (en) 16alpha-methyl or ethyl substituted estrogens.
MXPA03002734A (en) 5-amino-1-pentene-3-ol substituted derivatives.